This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
このページの翻訳は実験的なもので、現在 開発中です。お待ちしております！
Amryt Pharma 過去の業績
過去 基準チェック /06
主要情報
34.4%
収益成長率
59.1%
EPS成長率
| Pharmaceuticals 業界の成長 | 7.3% |
| 収益成長率 | 32.7% |
| 株主資本利益率 | -0.2% |
| ネット・マージン | -0.3% |
| 前回の決算情報 | 30 Sep 2022 |
最近の業績更新
Recent updates
収支内訳
収支内訳
Amryt Pharma の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Sep 22 | 244 | -1 | 124 | 38 |
| 30 Jun 22 | 239 | 3 | 119 | 41 |
| 31 Mar 22 | 233 | 3 | 112 | 39 |
| 31 Dec 21 | 223 | 1 | 100 | 38 |
| 30 Sep 21 | 210 | -88 | 90 | 34 |
| 30 Jun 21 | 203 | -81 | 83 | 30 |
| 31 Mar 21 | 186 | -92 | 82 | 28 |
| 31 Dec 20 | 183 | -105 | 81 | 28 |
| 30 Sep 20 | 180 | -87 | 80 | 31 |
| 30 Jun 20 | 140 | -92 | 68 | 26 |
| 31 Mar 20 | 98 | -87 | 52 | 23 |
| 31 Dec 19 | 58 | -63 | 36 | 16 |
| 31 Dec 18 | 17 | -30 | 18 | 11 |
質の高い収益: 3N9A is currently unprofitable.
利益率の向上: 3N9A is currently unprofitable.
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: 3N9A is unprofitable, but has reduced losses over the past 5 years at a rate of 34.4% per year.
成長の加速: Unable to compare 3N9A's earnings growth over the past year to its 5-year average as it is currently unprofitable
収益対業界: 3N9A is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (10.1%).
株主資本利益率
高いROE: 3N9A has a negative Return on Equity (-0.24%), as it is currently unprofitable.